Guanoxan (compound 1003) in the treatment of hypertension.
作者信息
Ozen M A, Kadiglu A
出版信息
Curr Ther Res Clin Exp. 1965 Sep;7(9):548-57.
PMID:4953855
Abstract
摘要
相似文献
1
Guanoxan (compound 1003) in the treatment of hypertension.胍生（化合物1003）治疗高血压。
Curr Ther Res Clin Exp. 1965 Sep;7(9):548-57.
2
[On the evaluation of therapeutic effects in hypertension (described by the example of Guanoxan)].[关于高血压治疗效果的评估（以胍生为例说明）]
Munch Med Wochenschr. 1965 Oct 22;107(43):2119-24.
3
Clinical evaluation of debrisoquin in the treatment of hypertension.降压嗪治疗高血压的临床评价。
Arch Intern Med. 1968 Dec;122(6):487-90.
4
[Treatment of renal hypertension with alpha-methylodopa (Presinol) and Cyclazenin (Leron)].用α-甲基多巴（普瑞西诺）和环拉嗪（勒龙）治疗肾性高血压
Med Klin. 1967 Apr 7;62(14):561-5.
5
6
[Medical treatment of arterial hypertension].
Brux Med. 1969 Apr;49(4):225-36.
7
[Effect of a combination of ergot alkaloids, reserpine and salidiuretics in the therapy of hypertension].麦角生物碱、利血平和利尿药联合应用治疗高血压的疗效
Wien Z Inn Med. 1968;49(8):292-9.
8
Eleven-year follow-up of a patient with malignant hypertension secondary to pyelonephritis and renal insufficiency.一名因肾盂肾炎和肾功能不全继发恶性高血压患者的11年随访。
Can Med Assoc J. 1968 Jul 27;99(4):184-6.
9
A long-term follow-up of drug treatment in severe hypertension.重度高血压药物治疗的长期随访
Scott Med J. 1966 Apr;11(4):113-8. doi: 10.1177/003693306601100401.
10
Management of hypertensive emergencies.高血压急症的管理
Indian Pediatr. 1992 Sep;29(9):1181-6.
Zotero 插件